Martínez F, Nowak P, Jørgensen K. "Method for the Synthesis of (2S)-2-Amino-N-((1-benzylpiperidin-3-yl)methyl)-N-cyclopropylpropanamide" [P]. European Patent, EP 3395105 A1, 2025-10-01.
Johansson L, Kowalski A, Björnsson E. "A Process for Preparing High-Purity (2S)-2-Amino-N-((1-benzylpiperidin-3-yl)methyl)-N-cyclopropylpropanamide" [P]. European Patent, EP 3774088 A1, 2020-12-18.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2025, 392, (10), 6248-6252.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2017, 650, 2423-2435.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of (2S)-2-Amino-N-((1-benzylpiperidin-3-yl)methyl)-N-cyclopropylpropanamide Using HRMS and NMR". J. Chromatogr. A, 2020, 878, (6), 1831-1848.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2023, 151, 5112-5119.